Atlas Trials

Radiomics Assess of Bevacizumab Plus Chemo in Colorectal Cancer Liver Metastases

Clinical trial NCT04213222 · UNKNOWN

Trial details

NCT number
NCT04213222
Sponsor
Peking University People's Hospital
Status
UNKNOWN
Study type
OBSERVATIONAL
Colon CancerRectal CancerLiver Metastases
Start date
2020-10-01
Primary completion
2022-06-01
Enrollment
300

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.